SCHEMBL6710239

SCHEMBL6710239

CCOC(=O)CC(=O)Nc1cccc2cc(C(=O)Nc3ccc(C#N)cc3-c3nnn[nH]3)[nH]c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.39
TP53 P04637 2/20 0.37
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
ALOX15 P16050 1/20 0.34
MAP3K5 Q99683 1/20 0.34
CSF1R P07333 2/20 0.34
RXFP1 Q9HBX9 1/20 0.33
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HPGD P15428 1/20 0.33
NSD2 O96028 1/20 0.33
PTK2B Q14289 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6711789 0.89 PARP14 (0.36) POLBTP53MAPTLMNAMAP3K5
SCHEMBL6708802 0.89 POLB (0.35) POLBTP53MAPTLMNAMAP3K5
SCHEMBL6709327 0.88 MEN1 (0.44) POLBTP53MAPTLMNAMAP3K5
SCHEMBL6708714 0.88 POLB (0.41) POLBTP53MAPTLMNAMAP3K5
SCHEMBL6712259 0.88 GAA (0.38) POLBTP53MAPTLMNAMAP3K5
SCHEMBL6709996 0.88 GSK3B (0.42) POLBTP53MAPTLMNAMAP3K5
SCHEMBL6709018 0.87 PKM (0.35) POLBTP53MAPTLMNAMAP3K5
SCHEMBL6708982 0.87 GSK3B (0.40) POLBTP53MAPTLMNAMAP3K5
SCHEMBL6708969 0.87 MAP3K5 (0.37) POLBTP53MAPTLMNAMAP3K5
SCHEMBL6711757 0.87 NR1H4 (0.35) POLBTP53MAPTLMNAMAP3K5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 POLB 626/4885TP53 2699/4885MAPT 4754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.